GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia

…, JM Cifrián, JM Olmos, M Carrascosa… - MedRxiv, 2020 - medrxiv.org
Background We aimed to determine whether a 6-day course of intravenous methylprednisolone
(MP) improves outcome in patients with SARS CoV-2 infection at risk of developing …

[HTML][HTML] Methylprednisolone in adults hospitalized with COVID-19 pneumonia: An open-label randomized trial (GLUCOCOVID)

…, JM Cifrián, JM Olmos, M Carrascosa… - Wiener klinische …, 2021 - Springer
… We thank Professor Jose Luis Pérez-Castrillón (Universidad de Valladolid) for useful discussion
and comments on the manuscript, and TICNOR (Santander, Spain) for … Jose M. Olmos …

[HTML][HTML] Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish …

…, P Ruiz, MA Ballesteros, C Álvarez, JM Cifrián… - American Journal of …, 2020 - Elsevier
Combining simultaneously lung and liver procurement in controlled donation after circulatory
death (cDCD) using normothermic abdominal perfusion (NRP) for abdominal grafts and …

Mortality analysis of patients undergoing lung transplantation for emphysema

…, F Zurbano, S Naranjo, J Llorca, JM Cifrián… - Archivos de …, 2009 - Elsevier
Introducción Se presentan los resultados del trasplante pulmonar (TP) en casos de enfisema,
tras 11 años desde el inicio del programa de TP, y se analizan los factores de riesgo …

Utility of home oximetry as a screening test for patients with moderate to severe symptoms of obstructive sleep apnea

R Golpe, A Jiménez, R Carpizo, JM Cifrian - Sleep, 1999 - academic.oup.com
Objective: To determine the value of home oximetry as a screening test in patients with
moderate to severe symptoms of obstructive sleep apnea (OSA). Design: Retrospective, …

[HTML][HTML] The spectrum of interstitial lung disease associated with autoimmune diseases: data of a 3.6-year prospective study from a referral center of interstitial lung …

…, MÁ González-Gay, JM Cifrián - Journal of Clinical …, 2020 - mdpi.com
Interstitial lung disease (ILD) may occur in patients with a rheumatic autoimmune disease (AD),
increasing their risk of morbidity and mortality. However, little is known about the …

[HTML][HTML] Rituximab in the treatment of interstitial lung disease associated with autoimmune diseases: experience from a single referral center and literature review

…, JJ Gómez-Román, JM Cifrián… - Journal of Clinical …, 2020 - mdpi.com
In the present study, we aimed to report our experience with rituximab (RTX) in the treatment
of patients with ILD associated with AD (AD-ILD) at a single center. For this purpose, clinical …

Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces

…, J Mayo, S Castañeda, JM Cifrián… - Expert opinion on …, 2020 - Taylor & Francis
In the past two decades, we have witnessed significant advances in the management of
autoimmune diseases. The widespread use of biologic therapies in patients with severe or …

[HTML][HTML] Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis

…, O Gualillo, I Ferraz-Amaro, JM Cifrián… - Frontiers in Molecular …, 2022 - frontiersin.org
Introduction: Early diagnosis of interstitial lung disease (ILD) associated with rheumatoid
arthritis (RA) constitutes a challenge for the clinicians. Pulmonary vasculopathy is relevant in …

Effect of an intensive lung donor-management protocol on lung transplantation outcomes

…, J Duerto, B Suberviola, R Mons, JM Cifrian… - The Journal of Heart and …, 2014 - Elsevier
Background An intensive lung donor-management protocol based on a strict protocol would
increase the lung procurement rate. The aim of this study was to determine the effect of such …